Carol L. Brosgart
CIK: 0001614724
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (0 total)
2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Brosgart Carol L
Brosgart Carol L (SEC CIK 0001614724) files insider reports with the SEC as Director of Cocrystal Pharma, Inc. (COCP) and Director of Galmed Pharmaceuticals Ltd. (GLMD).
Signal8 holds 2 ownership filings by Brosgart Carol L, all Form 3s, filed between Mar 18, 2026 and Aug 21, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Brosgart Carol L's filings is in BOTHELL, WA.
Other insiders filing for Cocrystal Pharma, Inc. (COCP)
- FROST PHILLIP MD ET AL, Director
- SAPIRSTEIN JAMES, Chief Executive Officer
- Kornberg Roger D., Director
- PFENNIGER RICHARD C JR, Director
- Lee Sam, President and Co-CEO
- Hassan Fred, Director